Cardiovascular Outcome Strategy Implications for Primary Care Westcliffe Medical Practice Shipley Westcliffe Cardiology Service Dr Matthew Fay Westcliffe.

Slides:



Advertisements
Similar presentations
Computers Cardiology and Primary Care
Advertisements

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham HIP for CHD Jane Matthews Practice Nurse Dr. Dai Evans PRIMIS Regional Clinical Adviser.
NCEP ATP IV GuidelineS: 2013 Update
Management of Atrial Fibrillation in Primary Care Dr Matthew Fay Westcliffe Medical Practice Shipley Westcliffe Cardiology Service.
Ischaemic Heart Disease- Implications of Gender Dr Kaye Birks School of Rural Health Monash University Australia Gender Competency Training for Medical.
ASCOT ASCOT STUDY. ASCOT INTRODUCTION AND AIMS EXISTING KNOWLEDGE BACKGROUND OF ASCOT STUDY DESIGN (TWO ARMS (BPLA,LLA) METHODOLOGY TREATMENT REGIMES.
Population Health Gain in Primary Care Dr Hilary Guite FFPH MRCGP Consultant Public Health Medicine Public Health England
Session 4 – Using Data (part 2)
Heart Disease Map.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
The United States & Heart Disease Presented today by; Matt Lorup, Keith Arline, & Nick Knight.
The Contribution of Mental Health Services to Tackling Health Inequalities Dr Alastair Cook Chair RCPsych in Scotland.
Evidence into Practice: Diabetes Public Health England May 2014 Dr Junaid Bajwa.
Prof Norman Sharpe Medical Director New Zealand Heart Foundation
Cardiovascular mortality in Russia and other countries
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
Diabetes and the Heart Meet the experts August Responding to the challenge: determining health policy Introductory remarks Lars Rydén Department.
Prevention Guidelines and the Risk of Nursing Home Admission Elmira Valiyeva, Ph.D., Rutgers Louise Russell, Ph.D., Rutgers Jane Miller, Ph.D., Rutgers.
Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
Improving the Quality of Physical Health Checks
Food in a Public Health Context Dr Eugene Milne Deputy Regional Director of Public Health.
Heart Health in Rotherham Looking at the most recent National trends in obesity Dr John Radford Director of Public Health.
Epidemiology of CV disease in Central and Eastern Europe Renata Cífková Center for CV Prevention, Charles University Medical School & Thomayer University.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
E VOLUTION OF THE P REVALENCE OF C ARDIOVASCULAR D ISEASE AND R ISK F ACTORS IN F EMALES AbdulRahman Ismaiel 5 th Year Medical Student UMF Carol Davila.
Studying mortality trends: The IMPACT CHD Policy Model
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
LIPID: Long-term Intervention with Pravastatin in Ischemic Disease Purpose To determine whether pravastatin will reduce coronary mortality and morbidity.
Urban-Rural Inequalities in Potentially Preventable Hospital Admissions Carolyn Hunter-Rowe Senior Health Intelligence Analyst Department of Public Health.
Assessing Changes in Diabetes Management and Diabetes Complications in Utah Ladene Larsen, RN Barbara Larsen, RD, MPH William Stinner, Ph.D. Sandra Assasnik,
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Comparison of two cardiovascular risk assessment tools to determine appropriate use of aspirin as primary prevention for patients with type 2 diabetes.
Cardiac MCN April 2007 Tackling Health Inequalities: Keep Well Programme.
Secondary Prevention of CHD in Primary Care. Nurse Led Clinics by Susan Neal Nurse Practitioner North Street Medical Care.
Chronic Disease Management Why is this an important issue? High numbers of patients affected Effective interventions may be available Concern that there.
Equal Treatment: Closing the gap Final results. Why we investigated ‘Far too many people…are dying in their 40s, 50s or even younger – far more than in.
NHS Health Check NHS Health Check Programme in Norfolk Presented by Justine Hottinger.
 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.
1 Pre-Specified Outcomes All primary and secondary outcomes and their components were pre-specified, i.e., they appeared in the protocol, manual of operations.
Airedale, Wharfedale and Craven Clinical Commissioning Group Julia Burrows Consultant in Public Health NHS Airedale, Bradford and Leeds.
Cardiovascular Disease Middlesbrough Update for Middlesbrough Scrutiny Committee 4 th November 2014 Dr Tanja Braun.
NHS West Kent Clinical Commissioning Group Level 3: Specialist Community Based Diabetes Service 2016/17 Dr Sanjay Singh, Chief GP Commissioner Dr Andrew.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
You & Your Care Improving the Quality of Physical Health Checks Kate Dale, Mental/Physical Health Project Lead BDCFT & YH AHSN.
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
Brighton and Hove PPMA Preventing Premature Mortality Audit Dr James Simpkin Clinical Facilitator BHPPMA
Presented by Slyter Nutrition Consulting Services.
Cardiovascular Risk: A global perspective
The cost of diabetes and diabetes care
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
The Anglo Scandinavian Cardiac Outcomes Trial
Prevention Cardiovascular disease
Cardiovascular Disease (CVD) in Texas
Irbedrin Group Training
2008 FDA Guidance. Working as a Team for Cardiovascular Risk Reduction in Patients With T2D.
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit  Barry A. Franklin, PhD  Mayo.
High Blood Pressure in General Practice: Variation and Opportunities South Cheshire CCG (v11) 5th March 2019.
Texas Framework For Heart Disease and Stroke Improved Quality of Life
Relative risks of clinical events for primary and secondary prevention with selected drugs Thomas A Gaziano, et al. Lancet 2006; 368:
Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.
Cardiovascular Disease in Women Module IX: Presentation Resources and Internet Resources This slide set was updated April 2008.
Section II: Lipid management
The Heart Truth Delaware Background
2017/18 National Diabetes Audit Cambridgeshire and Peterborough CCG local summary Public Health Intelligence, Cambridgeshire and Peterborough : April 2019.
Risk Stratification for Care Management
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
University College London
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Cardiovascular Outcome Strategy Implications for Primary Care Westcliffe Medical Practice Shipley Westcliffe Cardiology Service Dr Matthew Fay Westcliffe Medical Practice National Clinical Lead NHS Improvement

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Explaining the fall in CHD deaths in England Treatments-42% AMI treatments-8% AMI treatments-8% Secondary prevention-11% Secondary prevention-11% Heart failure-12% Heart failure-12% Angina: CABG/PCI-4% Angina: CABG/PCI-4% Angina: drugs-5% Angina: drugs-5% BP treatment-3% BP treatment-3% Risk factors worse +13% Obesity+3.5% Obesity+3.5% Diabetes+4.8% Diabetes+4.8% Less physical activity+4.4% Less physical activity+4.4% Risk factors better-71% Smoking-41% Smoking-41% Cholesterol-9% Cholesterol-9% Popul’n BP fall-9% Popul’n BP fall-9% Deprivation-3% Deprivation-3% Other factors-8% Other factors-8% 0 -20, , , , IMPACT model; Redrawn from Unal, Critchley & Capewell Circulation 2004;109(9): ,230 fewer deaths in 2000

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service The size of the gap - Males Bradford

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service Expected prevalence

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Westcliffe Medical Practice Shipley Westcliffe Cardiology Service

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.